Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats

null null null null We studied the effect of an eight-week treatment with telmisartan (5 mg kg null – 1 day null – 1 ) on cardiovascular complications that are associated with type 2 diabetes in a neonatal rat model. Type 2 diabetes was induced by the administration of 90 mg/kg streptozotocin (STZ), null ip , in two-day-old rats. The development of diabetes was checked 12 weeks after STZ administration, and the animals were divided into...